# ImmuCell completes $20M nisin production facility in Portland, Maine

ImmuCell Corp. completed construction of a $20 million, 16,000-square-foot pharmaceutical-grade factory in Portland, Maine, to produce nisin for treating dairy cows. The facility is awaiting FDA approval.

- Type: Expansion
- Announced: 2017-11-07
- Where: Portland, Maine, United States
- Value: $20.0M
- Status: completed
- Products: nisin antibacterial peptide
- Sectors: [Medical Devices](https://endata.com/sectors/medical-devices.md)

## Companies

- [ImmuCell](https://endata.com/companies/27921.md)

## Sources

- [centralmaine.com](https://www.centralmaine.com/2017/11/07/portland-biotech-firm-immucell-completes-20-million-expansion/), 2017-11-07: "Biotech firm ImmuCell Corp. of Portland has completed construction on a $20 million, pharmaceutical-grade factory"

---
Data from Endata (https://endata.com/). Announcements are summarized from public sources and may be incomplete; check the linked originals.